Login / Signup

Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.

Houot RochEmmanuel BachyGuillaume CartronFrançois-Xavier GrosFranck MorschhauserLucie ObericThomas GastinnePierre FeugierRémy DuléryCatherine ThieblemontMagalie JorisFabrice JardinSylvain ChoquetOlivier CasasnovasGabriel BrisouMorgane CheminantJacques-Olivier BayFrancisco Llamas GutierrezCédric MenardKarin TarteMarie-Hélène DelfauCédric PortuguesEmmanuel IttiXavier Palard-NovelloPaul Blanc-DurandYassine Al TabaaClément BaillyCamille LaurentFrançois Lemonnier
Published in: Nature medicine (2023)
Keyphrases
  • mesenchymal stem cells
  • stem cell transplantation
  • cell therapy
  • bone marrow
  • high dose
  • diffuse large b cell lymphoma
  • low dose
  • platelet rich plasma
  • stem cells